Vaccine companies develop biological products that train the immune system to recognise and respond to infectious agents, cancer-associated targets and other disease-related antigens. Their work spans human health, veterinary medicine and preparedness for emerging pathogens.
This category includes companies working on:
Browse 69 UK vaccine companies below.
Contract research for animal health, aquaculture and biopharmaceutical biosafety
Moredun Scientific is a contract research organisation providing efficacy and safety testing services for veterinary and aquaculture products, and biosafety testing of biopharmaceuticals. The company conducts studies across major livestock species and fish using validated infectious disease models for bacteria,…
Specialist vaccine development and GMP manufacturing in Scotland
Valneva Scotland Limited is the UK manufacturing and R&D subsidiary of Valneva SE, a specialty vaccine company. Operating from an MHRA-authorised GMP facility in Livingston, the site produces commercial and pipeline vaccines including IXCHIQ, the world's first approved chikungunya vaccine, and IXIARO for Japanese…
Specialist respiratory CRO delivering human challenge trials and preclinical models
Virtus Respiratory Research is a contract research organisation specialising in early-stage clinical and preclinical research for respiratory drug development. The company conducts human virus challenge trials and in vitro preclinical studies focused on asthma, COPD, respiratory virus infections, and related…
GLP/GMP biosafety testing centre of excellence for biologics and vaccines
SGS Vitrology is a biosafety testing contract research organisation operating from a 3,100m² GLP and GMP-accredited facility in Glasgow. The site serves as SGS's global centre of excellence for biosafety, providing cell bank characterisation, viral safety testing, mycoplasma detection, lot release testing, and…
Reagents that stabilise and fix RNA, DNA and tissue samples
RNAssist is a reagents company developing patented stabilisation and fixation products for biological samples. Its formulations, based on deep eutectic solvents, preserve RNA, DNA, proteins and cell structure at the point of collection and are compatible with downstream methods such as single-cell sequencing and…
University of Oxford GMP facility for clinical-grade biologics
The Clinical BioManufacturing Facility is the University of Oxford's GMP-licensed manufacturing facility, producing biological investigational medicinal products for early-phase clinical trials. The facility holds an MHRA Manufacturer's Authorisation for Investigational Medicinal Products and manufactures viral vector…
Generic, branded and biosimilar medicines across global therapeutic areas
Viatris UK Healthcare is the UK subsidiary of Viatris Inc., a global pharmaceutical company formed in 2020 through the combination of Mylan and Pfizer's Upjohn division. Operating from sites in Hertfordshire, Cambridge, and Sandwich, Kent, the UK entity carries out formulation and device research and development,…
Protein superglue vaccine platform targeting infectious disease and cancer
SpyBiotech is a clinical-stage biotechnology company developing vaccines using its proprietary protein superglue technology, which enables efficient and stable attachment of antigens to virus-like particle and viral vector delivery platforms. The approach improves immunogenicity and reduces manufacturing complexity…
Global influenza vaccine leader with major UK manufacturing in Liverpool
CSL Seqirus is one of the world's largest influenza vaccine companies, operating the only injectable influenza vaccine manufacturing facility in the UK at Speke, Liverpool. The site employs more than 650 people and produces egg-based and cell culture-derived influenza vaccines for seasonal and pandemic use, with surge…